Steven Xanthoudakis

Author PubWeight™ 9.38^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi.	Nat Cell Biol	2002	2.50
2	NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway.	J Biol Chem	2002	1.48
3	Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury.	J Biol Chem	2002	1.11
4	Differential efficacy of caspase inhibitors on apoptosis markers during sepsis in rats and implication for fractional inhibition requirements for therapeutics.	J Exp Med	2004	0.96
5	Gob-5 is not essential for mucus overproduction in preclinical murine models of allergic asthma.	Am J Respir Cell Mol Biol	2005	0.94
6	Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease.	Br J Pharmacol	2004	0.86
7	Solid-phase analogue synthesis of caspase-3 inhibitors via palladium-catalyzed amination of 3-bromopyrazinones.	Bioorg Med Chem Lett	2007	0.80
8	Solid phase synthesis of selective caspase-3 peptide inhibitors.	Bioorg Med Chem	2004	0.80
9	Correlating the fractional inhibition of caspase-3 in NT2 cells with apoptotic markers using an active-caspase-3 enzyme-linked immunosorbent assay.	Anal Biochem	2005	0.75
10	Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitors.	Bioorg Med Chem Lett	2005	0.75
11	Nicotinyl aspartyl ketones as inhibitors of caspase-3.	Bioorg Med Chem Lett	2003	0.75